OLMA - Olema Pharmaceuticals officer discloses sale of about 10K shares
2023-11-06 15:15:53 ET
More on Olema Pharmaceuticals
- Olema: Two-Pronged Approach To Treat Breast Cancer Patients
- Olema: Contrarian Small Cap Oncology Biotech (Reiterating Buy)
- Olema Pharmaceuticals up 6% on $180M financing
- Seeking Alpha’s Quant Rating on Olema Pharmaceuticals
- Historical earnings data for Olema Pharmaceuticals
For further details see:
Olema Pharmaceuticals officer discloses sale of about 10K shares